CCS Accelerator Grants

View the full funding opportunity here. The overarching goal of this funding program is to accelerate the application of high-quality evidence that is meaningful to people affected by cancer in the near term (i.e. 2-5 years). Through the Accelerator Grants, CCS will support research that addresses one of the following: (more…)

2022 BioCanRx Summer Studentship Program

Deadline: February 18, 2022 For More details/link to application visit: BioCanRx Summer Studentships provide funding for undergraduate and college students to gain work experience in the Canadian cancer biotherapeutics research sector. This funding opportunity is open to undergraduates and college students attending Canadian institutions, and to BioCanRx network investigators. (more…)

2022 Research Funding – Lymphoma Canada

Lymphoma Canada is pleased to announce that they are accepting applications for 2022 research funding until March 31. These funds are intended to support small, well-defined research studies that have the potential to effect improvements in healthcare, health systems, and/or health outcomes as they pertain to malignant lymphoproliferative diseases. Proposed (more…)
CIHR logo

CIHR Planning & Dissemination Grants

Application Deadline: February 1, 2022 For Full program details and to apply Click Here CIHR – Institute of Cancer Research (ICR) Summary/Relevance The CIHR Institute of Cancer Research (ICR) will provide funding for applications that are consistent with the mandate of the Institute and those that support the development of the (more…)

The 2022 CIHR Health System Impact (HSI) Fellowship

Application Deadline: 2022-02-24 Funding Start Date: 2022-09-01 Full details can be found by clicking here Description The Health System Impact (HSI) Fellowship (for doctoral trainees and post-doctoral fellows) provides highly-qualified doctoral trainees and post-doctoral fellows studying health services and policy research (HSPR), or related fields, a unique opportunity to apply (more…)

OICR Innovation Implementation Supplement- LOI Due Jan. 26th

RFA information session: January 12, 2022, 10-11 a.m. ET (register here. If you are unable to attend, a recording of the session will be made available on this website) Notice of Intent (NOI) deadline: January 26 by 5 p.m. ET Letter of Intent (LOI) deadline: January 26, 2022 by 5 p.m. ET (more…)

RFP – International Cancer Benchmarking Partnership COVID-19 Commissioned Research

Deadline to Submit Expression of Interest: October 22, 2021 Deadline for Full Proposal: November 1, 2021 Study Start Date: November 2021 Study Deadline: May 23, 2022 Budget: up to £40,000  (~$67,000 CAD) For full details see attached .pdf The ICBP is commissioning research that will develop an understanding how COVID-19 impacted cancer services and (more…)

*New* Patient Involvement in Cancer Research Program (PIP) Small Research Grant Competition

As part of its commitment to patient engagement in cancer research, the Canadian Cancer Research Alliance (CCRA) is releasing its inaugural funding opportunity as part of its Patient Involvement in Cancer Research Program (PIP). Integrated with the biennial Canadian Cancer Research Conference (CCRC) since 2017, PIP provides patient partners with (more…)

Terry Fox New Investigator Award

Registration Deadline for Intent to apply: June 25th, 2021. Full Application Deadline: September 10th, 2021 Visit for full detail and to apply. The Terry Fox New Investigator Awards support outstanding early career researchers as they develop their careers as independent research scientists or clinician-scientists to undertake high-quality cancer research while (more…)

CCS/CIHR Action Grants: Proof of Concept Interventions in Primary Cancer Prevention

Registration due date: June 23 2021 Full application due date: September 10 2021  The Canadian Cancer Society (CCS), and the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), are pleased to announce Phase 1 of the CCS/CIHR Initiative in Primary Cancer Prevention: CCS/CIHR Action Grants: Proof of (more…)